Related Experiment Video
Updated: May 19, 2026
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Dyspepsia.
1Division of Gastroenterology, McMaster University, Hamilton, Canada. moayyep@mcmaster.ca
Current Opinion in Gastroenterology
|August 25, 2012
Summary
Managing dyspepsia involves empirical treatment for Helicobacter pylori and proton pump inhibitors. Unresponsive cases of functional dyspepsia may benefit from future research into diet and gut microbiome interventions.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Therapeutics
Background:
- Dyspepsia, particularly epigastric pain, is common, with functional dyspepsia being the most frequent diagnosis.
- While organic causes exist, extensive investigation is often impractical due to the benign nature of most dyspepsia cases.
- Current guidelines recommend empirical treatment for Helicobacter pylori and proton pump inhibitors for uncomplicated dyspepsia.
Purpose of the Study:
- To review current management strategies for dyspepsia, focusing on functional dyspepsia.
- To explore emerging research and potential future therapeutic avenues for refractory cases.
- To highlight the challenges in managing patients with dyspepsia who do not respond to initial treatments.
Main Methods:
- Review of existing literature on dyspepsia management and treatment efficacy.
- Analysis of recent findings regarding potential pathophysiological mechanisms in functional dyspepsia.
- Evaluation of evidence for prokinetic therapy and other treatments.
Main Results:
- Prokinetic therapy for functional dyspepsia shows uncertain efficacy, with potential publication bias.
- Limited data exists on the effectiveness of tricyclic antidepressants for functional dyspepsia.
- Emerging research suggests a role for duodenal eosinophilia and altered mucosal immunity in functional dyspepsia, possibly linked to diet or microbiome changes.
Conclusions:
- Established initial management strategies for dyspepsia exist, but treatment of non-responsive cases remains a challenge.
- Future research focusing on dietary modifications and gut microbiome alterations may offer new therapeutic options for functional dyspepsia.
- Understanding the role of mucosal immunity and potential triggers like diet and microbiome is crucial for advancing functional dyspepsia treatment.
Related Concept Videos
01:11Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
01:30Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...